AKT1 and hepatocellular carcinoma: For example, ADAM17-induced chemoresistance drug resistance in hepatocellular carcinoma cells [19]and RLIP76-induced drug resistance in pancreatic cancer cells [20]were regulated by PI3K/AKT pathway.